Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APAF1 | O14727 | 1/20 | 0.62 |
| ▸ | MEN1 | O00255 | 3/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.53 |
| ▸ | CASR | P41180 | 2/20 | 0.53 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.53 |
| ▸ | HTR1A | P08908 | 1/20 | 0.53 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.53 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.53 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.53 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.53 |
| ▸ | DRD1 | P21728 | 1/20 | 0.53 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.53 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.53 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.53 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.53 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.53 |
| ▸ | DRD3 | P35462 | 1/20 | 0.53 |
| ▸ | HTR2B | P41595 | 1/20 | 0.53 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL653596 | 1.00 | APAF1 (0.62) | APAF1MEN1KMT2ACYP3A4CASR | |
| SCHEMBL157741 | 1.00 | APAF1 (0.62) | APAF1MEN1KMT2ACYP3A4CASR | |
| Glycine SCHEMBL27727845 | 0.93 | APAF1 (0.56) | APAF1MEN1KMT2ACYP3A4CASR | |
| SCHEMBL24433342 | 0.86 | APAF1 (0.61) | APAF1MEN1KMT2ACYP3A4CASR | |
| SCHEMBL1049426 | 0.85 | APAF1 (0.46) | APAF1MEN1KMT2A | |
| SCHEMBL1881712 | 0.85 | APAF1 (0.59) | APAF1MEN1KMT2ACYP3A4CASR | |
| SCHEMBL1881711 | 0.85 | APAF1 (0.59) | APAF1MEN1KMT2ACYP3A4CASR | |
| SCHEMBL6809830 | 0.83 | APAF1 (0.57) | APAF1MEN1KMT2ACYP3A4CASR | |
| SCHEMBL2408159 | 0.83 | APAF1 (0.57) | APAF1MEN1KMT2ACYP3A4CASR | |
| SCHEMBL2408156 | 0.83 | APAF1 (0.57) | APAF1MEN1KMT2ACYP3A4CASR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 178 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025038979-A1 | COMPOSITIONS AND METHODS FOR PROPHYLAXIS AND/OR TREATMENT OF AMYLOID B PEPTIDE PROTEINOPENIA IN ALZHEIMER'S AND OTHER DISEASES | LVIS-Regain LP (US) | 2025-02-20 | — | — | WO | claimed |
| US-20240360177-A1 | PEPTIDES WITH ANTIMICROBIAL ACTIVITIES | AIMMAX THERAPEUTICS, INC. | 2024-10-31 | — | — | US | claimed |
| CN-117897394-A | Peptides with antimicrobial activity | 美商安满药物开发公司 | 2024-04-16 | — | — | CN | claimed |
| EP-3994238-B1 | LUBRICATING COMPOSITIONS CONTAINING BASIC ASHLESS ADDITIVES | LUBRIZOL CORP (US) | 2024-03-13 | — | — | EP | claimed |
| US-11859148-B2 | Basic ashless additives and lubricating compositions containing same | THE LUBRIZOL CORPORATION (US) | 2024-01-02 | — | — | US | claimed |
| EP-3328877-B1 | PEPTOID | THE UNIV OF DURHAM (GB) | 2022-08-24 | — | — | EP | claimed |
| CN-114105811-A | New etomidate impurity, preparation method and application thereof | 北京四环制药有限公司 | 2022-03-01 | — | — | CN | claimed |
| US-10676509-B2 | Surface-immobilized antimicrobial peptoids | NORTHWESTERN UNIVERSITY (US) | 2020-06-09 | — | — | US | claimed |
| US-20180201647-A1 | Peptoid | THE UNIVERSITY OF DURHAM (GB) | 2018-07-19 | — | — | US | claimed |
| EP-0017850-B1 | N,N-DISUBSTITUTED ETHYLGLYCINE ESTERS, THEIR PREPARATION AND USE, FUNGICIDES CONTAINING THEM AND THEIR PREPARATION | BAYER AG (DE) | 1982-12-08 | — | — | EP | claimed |
| EP-4731270-A1 | COMBINATION THERAPY WITH PEPTIDE RECEPTOR RADIONUCLIDE AND DNA REPAIR INHIBITOR | The Regents of The University of California (US) | 2026-04-29 | — | — | EP | disclosed |
| US-20260083852-A1 | PROTEOGLYCAN MIMETICS FOR ENHANCED WOUND HEALING, ANGIOGENESIS, AND VASCULAR REPAIR | UNIV CALIFORNIA (US) | 2026-03-26 | — | — | US | disclosed |
| US-12485182-B2 | Proteoglycan mimetics for enhanced wound healing, angiogenesis, and vascular repair | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-12-02 | — | — | US | disclosed |
| WO-2025038979-A1 | COMPOSITIONS AND METHODS FOR PROPHYLAXIS AND/OR TREATMENT OF AMYLOID B PEPTIDE PROTEINOPENIA IN ALZHEIMER'S AND OTHER DISEASES | LVIS-Regain LP (US) | 2025-02-20 | — | — | WO | disclosed |
| WO-2025005781-A1 | ANTIMICROBIAL PEPTOID COMPRISING N-TERMINAL METAL COMPLEX | 광주과학기술원 | 2025-01-02 | — | — | WO | disclosed |
| EP-0489767-A1 | CCK ANTAGONISTS. | BIOMEASURE INC (US) | 1992-06-17 | — | — | EP | disclosed |
| WO-1991019735-A1 | LIBRARIES OF MODIFIED PEPTIDES WITH PROTEASE RESISTANCE | BARTLETT PAUL A (US) | 1991-12-26 | — | — | WO | disclosed |
| WO-1991002719-A2 | CCK ANTAGONISTS | BIOMEASURE, INC. (US) | 1991-03-07 | — | — | WO | disclosed |
| EP-0017850-B1 | N,N-DISUBSTITUTED ETHYLGLYCINE ESTERS, THEIR PREPARATION AND USE, FUNGICIDES CONTAINING THEM AND THEIR PREPARATION | BAYER AG (DE) | 1982-12-08 | — | — | EP | disclosed |
| EP-0017850-A1 | N,N-disubstituted ethylglycine esters, their preparation and use, fungicides containing them and their preparation | BAYER AG (DE) | 1980-10-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180201647-A1 | Peptoid | ARG1, ARGLU1, QPCT | APAF1 4395/4885MEN1 988/4885KMT2A 1117/4885 |
| US-12485182-B2 | Proteoglycan mimetics for enhanced wound healing, angiogenesis, and vascular repair | PDGFA, PDGFRB, TEK | APAF1 1685/4885MEN1 4811/4885KMT2A 4334/4885 |
| US-20260083852-A1 | PROTEOGLYCAN MIMETICS FOR ENHANCED WOUND HEALING, ANGIOGENESIS, AND VASCULAR REPAIR | PDGFA, DCLRE1A, PDGFRA | APAF1 2410/4885MEN1 4697/4885KMT2A 2690/4885 |
| US-20240360177-A1 | PEPTIDES WITH ANTIMICROBIAL ACTIVITIES | VIP, FPR2, FPR1 | APAF1 298/4885MEN1 3021/4885KMT2A 4839/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.